GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Vitaspring Biomedical Co. VSBC · USD

N/A · US listing · 🇺🇸 United States

Compare

0.02

—

Close of 5 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2026

Revenue

—

FY2017FY2026

Net income

−$415,368

FY2017FY2026

Free cash flow

−$2,692

FY2017FY2026

Shareholders' equity

−$4.4m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue————$5.6m$248,200$15,140$17,180$16,230—
Operating income−$385,411−$679,914−$1.1m−$4.2m$1.5m−$424,712−$19,486−$21,330−$5,780−$45
Net income−$415,368−$774,922−$1.1m−$4.2m$1.3m−$425,382$6,919−$22,396−$6,374−$45
Diluted earnings per share-0.00-0.00-0.01-0.020.01-0.000.00-0.00-0.00-0.00

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets$14,676$14,378$137,342$765,948$3.6m$189,398—$11,431$12,891$4,555
Cash and short-term investments$2,084———$107,212$45,398—$105$5,207$555
Total liabilities$4.4m$4.0m$3.5m$3.2m$2.0m$93,034—$18,350$16,310$1,600
Debt$262,981———$463,572——$18,350$8,100$1,600
Shareholders' equity−$4.4m−$4.0m−$3.4m−$2.4m$1.6m$386,771−$18,262−$6,919−$3,419$2,955
Shares outstanding207m207m207m207m207m207m55m55m55m55m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−$2,688−$14,675−$34,920−$77,556$84,811−$42,130−$105−$34,248$401−$4,045
Capital spending−$4———−$72,997———−$2,249−$2,249
Free cash flow−$2,692−$14,675−$34,920−$77,556$11,814−$42,130−$105−$34,248−$1,848−$6,294

Latest quarters

By quarter end

Jul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Oct 2024Jul 2024
Operating income−$161,817−$75,844−$81,464−$135,733−$99,067−$69,147−$117,927−$218,662
Net income−$155,817−$75,844−$81,464−$142,518−$110,845−$80,541−$196,292−$218,662
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Total assets$14,822$11,432$14,676$16,465$17,020—$58,382$64,334
Cash and short-term investments$13,367$8,167——————
Debt$2.4m———————
Shareholders' equity−$4.7m−$4.5m−$4.4m−$4.3m−$4.2m—−$3.9m−$3.7m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-54.8%-1.9%—
Net income-53.6%-0.5%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2021FY2019
Price to earnings-15.8-267.2-2961.4-795.4-9467.1-1022.3

Share price return

Finished calendar years

2025202420232022202120202019
Return-94%0%5%-22%63%2757%0%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 5-for-1 split · 29 Jun 2020

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.